Acute onset chronic inflammatory demyelinating polyneuropathy or Guillain-Barre syndrome?, A case with delayed treatment of plasmapheresis

Key Points

• Plasmapheresis treatment was initiated late, impacting recovery outcomes for the patient.
• The case highlights distinct clinical features of chronic inflammatory demyelinating polyneuropathy and Guillain-Barre syndrome.
• Neurophysiological assessment played a key role in distinguishing between the two conditions.
• Early intervention is crucial in managing autoimmune conditions like chronic inflammatory demyelinating polyneuropathy.